Skip to main content
Rural Health Information Hub

Website Search Results for: diabetes

586 webpages matched your search. Here are matches 91 - 100:

91. Differences in GLP-1 RA Medication Adherence Across Place-Based Variables in Patients with Diabetes Living in Wisconsin - Resources
Date: Nov 2025

Analyzes adherence to GLP-1 RA medications for diabetes treatment among Wisconsin adults by geographic and demographic group, utilizing 2020-2022 Wisconsin Health Information Organization data. Compares adherence by rural or urban status, among other factors.

...Diabetes Living in Wisconsin --- Analyzes adherence to GLP-1 RA medications for diabetes treatment among...

92. Enhancing Access and Impact of the Medicare Diabetes Prevention Program Using Telehealth: A Narrative Review - Resources
Date: Dec 2023

Evaluates the viability of telehealth delivery of the Medicare Diabetes Prevention Program (MDPP) via a literature review of telehealth-based disease prevention program research. Discusses clinical effectiveness, feasibility and acceptability, and policies affecting MDPP implementation. Highlights rural-relevant research findings and discusses access benefits of remote delivery.

...Diabetes Prevention Program Using Telehealth: A Narrative Review --- Evaluates the viability of telehealth delivery of the Medicare...

93. Patterns of Sustainability Capacity Among Organizations That Deliver the National Diabetes Prevention Program: A Latent Profile Analysis - Resources
Date: Oct 2023

Examines sustainability of National Diabetes Prevention Programs (DPPs) since they began in 2010. Analyzes 440 surveys taken in 2021 by staff members at National DPP delivery organizations to better understand issues such as environmental support, funding stability, partnerships, organizational capacity, program evaluation and adaptation, communications, and strategic planning. Includes sustainability scores of DPPs in rural, suburban, and urban locations.

...Diabetes Prevention Program: A Latent Profile Analysis --- Examines sustainability of National Diabetes Prevention Programs (DPPs...

94. Screening and Referral Programs for Diabetes and Cardiovascular Disease: Can Community Pharmacists Bridge the Care Gap? - Resources
Date: Mar 2025

Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&R in 6 community pharmacies, with both rural and urban locations represented.

...Diabetes and Cardiovascular Disease: Can Community Pharmacists Bridge the Care Gap? --- Examines the community-based...

95. Long-Term Mortality Trends in Patients with Concurrent Hernia and Diabetes in the United States - Resources
Date: Feb 2026

Analyzes demographic variations in long-term mortality trends among patients with both hernia and diabetes mellitus as contributing causes of death, using 1999-2023 CDC WONDER data. Includes data comparisons by metropolitan or nonmetropolitan area, among other factors.

...Diabetes in the United States --- Analyzes demographic variations in long-term mortality trends among patients...

96. Evaluation of the 2021–2024 Implementation of the Fresh Start Enhanced Food Is Medicine Intervention Among Rural, Underinsured People With Type 2 Diabetes - Resources
Date: Jul 2026

Examines the impact of the Fresh Start produce prescription (FSPRx) intervention in rural North Carolina among a medically underinsured population with type 2 diabetes. Utilizes program, survey, and interview data from FSPRx participants to analyze feasibility and acceptability of the program, with pre- and post-intervention data breakdowns according to dietary patterns, food literacy, health outcomes, and more.

...Diabetes --- Examines the impact of the Fresh Start produce prescription (FSPRx) intervention in rural North...

97. Geographic and Sociodemographic Patterns in Prevalence of Diagnosed Diabetes, US, 2021–2024 - Resources
Date: Apr 2026

Analyzes the prevalence of diagnosed diabetes in rural and urban populations using 2021-2024 NHIS data. Includes rural-urban data comparisons by sociodemographic group, including sex, age, body mass index, race and ethnicity, income level, food security status, and more.

...Diabetes, US, 2021–2024 --- Analyzes the prevalence of diagnosed diabetes in rural and urban populations...

98. Medicaid Coverage of the National Diabetes Prevention Program: Considerations for Texas - Resources
Date: Jun 2026

Offers key considerations for implementing the National Diabetes Prevention Program (DPP) as a Medicaid-covered benefit in Texas. Synthesizes findings from interviews with representatives from 6 states and features a state-level map with colors indicating coverage mechanisms for the program. Mentions rural throughout.

...Diabetes Prevention Program: Considerations for Texas --- Offers key considerations for implementing the National Diabetes Prevention...

99. Demographic Profiles and Disparities in All Liver Diseases and Diabetes Mellitus Patients - Related Mortality among Older Adults (≥ 65) in the United States, 1999 to 2020 - Resources
Date: Apr 2026

Examines mortality rates of diabetes mellitus (DM) and all liver diseases (All-LD) in older adults from 1999 to 2020 in the United States. Utilizes the CDC-WONDER Multiple Cause of Death database to analyze 95,870 deaths related to All-LD and DM according to demographics, census region, place of death, and metro versus nonmetro location.

...Diabetes Mellitus Patients - Related Mortality among Older Adults (≥ 65) in the United States, 1999 to 2020 --- Examines...

100. Geographic Variation and Racial Disparities in Adoption of Newer Glucose-Lowering Drugs with Cardiovascular Benefits among US Medicare Beneficiaries with Type 2 Diabetes - Resources
Date: Jan 2024

Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes, utilizing 2017-2018 Medicare Part D beneficiary claims data. Identifies rural-urban and racial disparities in GLD initiation rates, and discusses factors influencing equitable access to cardiovascular treatment.

...Diabetes --- Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes...